Encouraging Shared Decision-Making with MS Patients
Recent Developments in Immune Therapies for Multiple Sclerosis
The Connection Between Viruses and Other Factors Contributing to the Development of MS
Healthcare providers who prescribe opioid analgesics or mycophenalates have a responsibility to help ensure the safe and effective use of these agents. Our FDA REMS-compliant CME/CE activities focus on safe prescribing.
A ACCME Accredited provider.
The France Foundation ©
10 Vista Drive, Old Lyme, CT USA